FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(079937015)" | 70092-612 | 70092-612-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2026-1 | valid | 2026-10-06 | ||
| QuVa Pharma, Inc. | 70092-612 | 70092-612-44 | L.E.T. Gel 1.5 ml in 3 ml Top Syr | L.E.T. Gel 1.5 ml in 3 ml Top Syr | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2026-1 | valid | 2026-09-18 | |
| "QuVa Pharma, Inc.(079937015)" | 70092-612 | 70092-612-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2025-2 | valid | 2026-10-06 | ||
| QuVa Pharma, Inc. | 70092-612 | 70092-612-44 | L.E.T. Gel 1.5 ml in 3 ml Top Syr | L.E.T. Gel 1.5 ml in 3 ml Top Syr | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2025-2 | valid | 2026-09-18 | |
| "QuVa Pharma, Inc.(079937015)" | 70092-612 | 70092-612-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2025-1 | valid | 2026-10-06 | ||
| QuVa Pharma, Inc. | 70092-612 | 70092-612-44 | L.E.T. Gel 1.5 ml in 3 ml Top Syr | L.E.T. Gel 1.5 ml in 3 ml Top Syr | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2025-1 | valid | 2026-09-18 | |
| "QuVa Pharma, Inc.(079937015)" | 70092-612 | 70092-612-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2024-2 | valid | 2026-10-06 | ||
| QuVa Pharma, Inc. | 70092-612 | 70092-612-44 | L.E.T. Gel 1.5 ml in 3 ml Top Syr | L.E.T. Gel 1.5 ml in 3 ml Top Syr | 60 mg/1.5 mL; 7.5 mg/1.5 mL; .75 mg/1.5 mL | 2024-2 | valid | 2026-09-18 |